Clinical trial NCT02165917: Study to Compare Peritoneal Ablation by Excision Only and Excision With the Use of an Adhesion Barrier
Official title: Randomised, Controlled Clinical Study With Patients With Endometriosis and the Desire to Have Children - Comparison Between Peritoneal Ablation by Excision Only and Excision With the Use of an Adhesionbarrier
Study type: INTERVENTIONAL
Overall status: UNKNOWN
Phase: PHASE4
Conditions: Endometriosis
Keywords: Endometriosis
Adhesions
Hyalobarrier®
Hyaluronic acid
Antiadhesion agent
Adhesionbarrier
Pregnancy rate
Lead sponsor: Pius-Hospital Oldenburg
Sponsor class: OTHER
First posted: 2014-06-18
Enrollment: 60
Sex: FEMALE
Minimum age (years): 18
Maximum age (years): 45
Standard ages: ADULT
Accepts healthy volunteers: no
Allocation: RANDOMIZED
Intervention model: PARALLEL
Primary purpose: TREATMENT

Brief summary: Endometriosis is a common disease of women in the reproductive age and is an important cause for female infertility. Endometriosis is often associated with the development of adhesions which further compromises the fertility of the affected women. The main purpose of this study is to investigate the pregnancy rate one year after excision of endometriosis and application of GnRH-analogues (Gonadotropin-releasing hormone) for 3 month. Half of the patients will receive traditional endometriosis treatment with the excision of the endometriotic lesions only. The other half will additionally receive a gel which can reduce adhesion formation (Hyalobarrier®). Further study objective is the investigation in the development of different types of endometriosis-associated pain over a period of one year. Potential study participants are women with endometriosis-associated pain and with a desire to have children. It will be investigated in the study if the use of Hyalobarrier® will result in a higher pregnancy rate due to reduced adhesion development.

Detailed description: Design: Prospective, monocentric, comparative, randomized, semi-blind.

There will be 30 subjects in each arm, who will be followed 15 months after surgery.

Half of the patients will receive standard laparoscopic excision of the endometriotic lesions only. The other half, after the excision of the endometriosis foci, will receive 10 cc of an antiadhesion agent which contents hyaluronic acid gel (Hyalobarrier®).The subjects will be hospitalized after surgery for at least 2 days.

A Vas-Scala will be given to the subjects to estimate the pain before, after surgery and one year after treatment. The participants will record the values each three months after surgery.

All subjects will be asked by telephone for the VAS-scala values and for pregnancy (Date of Initiation, clinical evolution)

The participation ist voluntary and an Informed consent must be signed before surgery. Subjects are free to withdraw their consent anytime.

Eligibility criteria: Inclusion Criteria:

* Women over 18 years with endometriosis-associated pain, like dysmenorrhea, dyspareunia, lower abdominal pain, low-back pain, rectal pain, defecation pain (only one criterion needs to be fulfilled for study inclusion);
* Participants are in good general health except for endometriosis related problems;
* Except for endometriosis, no existence of an obvious diseases which could cause chronic pain or which could cause abdominal pain;
* The participant must have a desire to have children;
* Participants must be able to give their consent and must understand the risks associated with a participation in the study;
* There must be a signed and dated informed consent which was accepted by the local ethic committee

Exclusion Criteria:

* Existent pregnancy including ectopic pregnancy;
* Identification of other causes for the discomfort;
* Chronic diseases, except endometriosis, which require continuous pain therapy;
* Previous application of GnRH analogues 6 month prior to study;
* Concurrent use of systemic corticosteroids, antineoplastic agents and/or radiation;
* Planned additional general surgical procedures during the operation for removal of the endometriotic lesions;
* Absence of endometriosis at laparoscopy;
* Partial resection of the bowel or urinary bladder for removal of endometriosis

Primary outcomes:
measure: Pregnancy rate
timeFrame: One year after completion of endometriosis treatment (excision followed by 3 month of GnRH-analogues)
Secondary outcomes:
measure: Endometriosis-associated pain
timeFrame: The day before laparoscopy is performed
measure: Endometriosis-associated pain
timeFrame: One year after completion of endometriosis treatment
Other outcomes:
Locations:
city: Oldenburg
country: Germany
facility: Pius-Hospital, Department of Gynecology, Obstetrics and Gynecological Oncology, Carl von Ossietzky University
state: Lower Saxony
Study officials:
affiliation: Pius-Hospital Oldenburg, Department of Gynecology, Obstetrics and Gynecological Oncology
name: Rudy L De Wilde, Professor
role: PRINCIPAL_INVESTIGATOR
References: